Polar Asset Management Partners Inc. Charles River Laboratories International, Inc. Transaction History

Polar Asset Management Partners Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$194.44 - $217.61 $9.22 Million - $10.3 Million	47,400 New	47,400 $9.29 Million
Q1 2023 May 15, 2023	BUY	$191.89 - $259.92 $3.24 Million - $4.39 Million	16,900 Added 77.52%	38,700 $7.81 Million
Q4 2022 Feb 14, 2023	SELL	$197.11 - $250.07 $14.5 Million - $18.4 Million	-73,500 Reduced 77.12%	21,800 $4.75 Million
Q3 2022 Nov 14, 2022	BUY	$182.44 - $250.54 $17.4 Million - $23.9 Million	95,300 New	95,300 $18.8 Million
Q1 2021 May 17, 2021	SELL	$249.67 - $299.48 $34 Million - $40.7 Million	-136,000 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$222.0 - $252.62 $6.82 Million - $7.76 Million	-30,700 Reduced 18.42%	136,000 $34 Million
Q3 2020 Nov 16, 2020	BUY	$175.56 - $226.45 $17 Million - $21.9 Million	96,700 Added 138.14%	166,700 $37.7 Million
Q2 2020 Aug 14, 2020	BUY	$118.84 - $189.72 $736,808 - $1.18 Million	6,200 Added 9.72%	70,000 $12.2 Million
Q1 2020 May 15, 2020	BUY	$98.9 - $178.34 $6.31 Million - $11.4 Million	63,800 New	63,800 $8.05 Million

698

52.3M

259K

463K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $10.1B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of Polar Asset Management Partners Inc., based on Form 13F filings with the SEC.

Stay updated on Polar Asset Management Partners Inc. with notifications on news.